Sichuan Chenghua Biotechnology Co., Ltd. is a research and development, production, sales in one of the diversified, professional pharmaceutical production company.
The company has launched a number of research and development projects in the field of high-end generic intermediates, covering multiple disease areas such as anti-infection, digestive system and diabetes. Through the innovation of synthetic biology pharmaceutical technology, the company effectively solves the problems of high pollution, high risk and high consumption in the preparation of drugs and their intermediates. At present, the key products include Isaconazole intermediates, posaconazole intermediates,Obecholic acid, ursodeoxycholic acid, tauroursodeoxycholic acid, obecholic acid intermediates, etc.
The company has passed the "National high-tech Enterprise" identification, has ISO9001 quality management system certificate.
Main products: ursodeoxycholic acid, deoxycholic acid, deoxycholic acid, deoxycholic acid, deoxycholic acid oxide, Esaconazole intermediates, Posaconazole intermediates, Obercholic acid, omacycline and other pharmaceutical intermediates, API and impurity reference products
Year of Establishment:
2015
Total Assets(USD):
Total Number of Staff:
10-50
Main Competitive Advantages:
Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted
Other Competitive Advantages:
Cholic acids
chenodeoxycholic Acid
7-K
Isavuconazole intermediate
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
Asia,Middle East
Other Competitive Advantages:
Cholic acids
chenodeoxycholic Acid
7-K
Isavuconazole intermediate
Patents and Copyrights:
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
